International Journal of Molecular Sciences (Apr 2022)

The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas

  • Sergio Andonegui-Elguera,
  • Gloria Silva-Román,
  • Eduardo Peña-Martínez,
  • Keiko Taniguchi-Ponciano,
  • Sandra Vela-Patiño,
  • Ilan Remba-Shapiro,
  • Erick Gómez-Apo,
  • Ana-Laura Espinosa-de-los-Monteros,
  • Lesly A. Portocarrero-Ortiz,
  • Gerardo Guinto,
  • Sergio Moreno-Jimenez,
  • Laura Chavez-Macias,
  • Renata Saucedo,
  • Lourdes Basurto-Acevedo,
  • Blas Lopez-Felix,
  • Carolina Gonzalez-Torres,
  • Javier Gaytan-Cervantes,
  • Jorge T. Ayala-Sumuano,
  • Andres Burak-Leipuner,
  • Daniel Marrero-Rodríguez,
  • Moisés Mercado

DOI
https://doi.org/10.3390/ijms23094861
Journal volume & issue
Vol. 23, no. 9
p. 4861

Abstract

Read online

Corticotroph cells give rise to aggressive and rare pituitary neoplasms comprising ACTH-producing adenomas resulting in Cushing disease (CD), clinically silent ACTH adenomas (SCA), Crooke cell adenomas (CCA) and ACTH-producing carcinomas (CA). The molecular pathogenesis of these tumors is still poorly understood. To better understand the genomic landscape of all the lesions of the corticotroph lineage, we sequenced the whole exome of three SCA, one CCA, four ACTH-secreting PA causing CD, one corticotrophinoma occurring in a CD patient who developed Nelson syndrome after adrenalectomy and one patient with an ACTH-producing CA. The ACTH-producing CA was the lesion with the highest number of single nucleotide variants (SNV) in genes such as USP8, TP53, AURKA, EGFR, HSD3B1 and CDKN1A. The USP8 variant was found only in the ACTH-CA and in the corticotrophinoma occurring in a patient with Nelson syndrome. In CCA, SNV in TP53, EGFR, HSD3B1 and CDKN1A SNV were present. HSD3B1 and CDKN1A SNVs were present in all three SCA, whereas in two of these tumors SNV in TP53, AURKA and EGFR were found. None of the analyzed tumors showed SNV in USP48, BRAF, BRG1 or CABLES1. The amplification of 17q12 was found in all tumors, except for the ACTH-producing carcinoma. The four clinically functioning ACTH adenomas and the ACTH-CA shared the amplification of 10q11.22 and showed more copy-number variation (CNV) gains and single-nucleotide variations than the nonfunctioning tumors.

Keywords